(lp0
S"Endocyte's NSCLC Drug: Any Residual Value? Seeking Alpha - Mar 24, 2017 Endycyte  develops small molecule drug conjugates and companion diagnostics for the treatment of cancer and inflammatory diseases."
p1
aS"Company Update : Endocyte, Inc. and Seattle Children's Research ... Smarter Analyst - Mar 10, 2017 Endocyte, Inc.  announced their plan to collaborate with Seattle Children's Research Institute and Dr.Endocyte  Reports a Wider Q4 Loss - Yahoo FinanceEndocyte, Inc.  Misses But Shares Rise - StockNewsUnion"
p2
aS"Endocyte Announces Presentations at American Association for Cancer Research ... GlobeNewswire  - Mar 27, 2017 WEST LAFAYETTE, Ind., March 27, 2017  -- Endocyte, Inc. , a leader in developing targeted small molecule drug conjugates  and companion imaging agents for personalized therapy, today announced that&nbsp;...What's Happening To These Stocks?  Endocyte, Inc. , Trevena, Inc.  - Post AnalystEndocyte, Inc.  eight posters will be presented by Endocyte ... - Benchmark Monitor"
p3
aS'Endocyte Appoints Michael T. Andriole as Chief Financial Officer GlobeNewswire  - Feb 21, 2017 WEST LAFAYETTE, Ind., Feb. 21, 2017  -- Endocyte, Inc. , a leader in developing targeted small molecule drug conjugates  and companion imaging agents for personalized therapy, today announced that&nbsp;...Endocyte  Appoints Michael Andriole as CFO - StreetInsider.com'
p4
aS'Endocyte: A Must Buy While Wall Street Goes Insane Seeking Alpha - Jan 21, 2016 During past few months, while the whole biotech sector has been melting down, Endocyte  has been no exception.'
p5
aS'Endocyte to Present at the IASLC 17th World Conference on Lung Cancer GlobeNewswire  - Dec 1, 2016 WEST LAFAYETTE, Ind., Dec. 01, 2016  -- Endocyte, Inc. , a leader in developing targeted small molecule drug conjugates  and companion imaging agents for personalized therapy, today announced that data&nbsp;...'
p6
aS'Endocyte Inc.  Plunges 7.25% on March 14 Equities.com - Mar 14, 2017 Endocyte Inc.  had a rough trading day for Tuesday March 14 as shares tumbled 7.25%, or a loss of $-0.19 per share, to close at $2.43.Endocyte  Reports Wider-than-Expected Loss in Q4 - NasdaqEndocyte, Inc. Forecasted to Post FY2021 Earnings of $0.72 Per Share  - BNB Daily '
p7
aS'Company Update : Endocyte, Inc. Presents Data on Two Lead ... Smarter Analyst - Oct 10, 2016 Endocyte, Inc.  presented poster updates on its two lead clinical programs at the ESMO 2016 Congress, being held in Copenhagen, Denmark October 7-11, 2016.'
p8
aS'Endocyte Inc.  Plunges 8.33% on March 21 Equities.com - Mar 21, 2017 Endocyte Inc.  had a rough trading day for Tuesday March 21 as shares tumbled 8.33%, or a loss of $-0.2 per share, to close at $2.20.A Look Ahead For 2 Stocks: Endocyte, Inc. , TimkenSteel Corporation  - Post AnalystRecent Trading Updates: Endocyte, Inc.  - Is stories'
p9
aS"Endocyte Appoints Mike Sherman as President and Chief Executive Officer GlobeNewswire  - Jun 20, 2016 WEST LAFAYETTE, Ind., June 20, 2016  -- Endocyte, Inc. , a leader in developing targeted small molecule drug conjugates  and companion imaging agents for personalized therapy, today announced that Mike&nbsp;...After failures and partnership breaks, Endocyte CEO retires - FierceBiotechMike Sherman '88 Named President &amp; CEO of Endocyte - DePauw University"
p10
a.